Gülser Esen BESLİ, SEMA YILDIRIM, İbrahim AKALIN, Yusuf İzzet AYHAN, Merve KİŞİOĞLU, Afig BERDELİ

Fever-induced Brugada syndrome in a 9-year-old boy presenting with acute chest pain

Brugada syndrome, an arrhythmogenic disease, occurs due to mutationsinvolving cardiac sodium channels. It is characterized by persistent or transientST-segment elevation in the right precordial electrocardiogram leads that couldbe unmasked by several circumstances, with fever particularly. Molecular andcellular mechanisms leading to Brugada syndrome have not been completelyelucidated. Mutations of the SCN5A gene encoding the pore-forming α-subunitof the cardiac sodium channel protein have been attributed in the moleculardiagnosis. Although this syndrome is well-known in adults, it is less frequentlyreported in infants and children. We describe a 9-year-old Turkish boy witha family history of sudden cardiac death, who presented with chest pain andfever-induced expression of the Brugada syndrome phenotype that might beassociated with a mutation in SCN5A gene.

PDF

___

1. Brugada P, Brugada J. Right bundle branch block, persistent ST segment elevation and sudden cardiac death: A distinct clinical and electrocardiographic syndrome. A multicenter report. J Am Coll Cardiol 1992; 20: 1391-1396.

2. Wilde AA, Antzelevitch C, Borggrefe M, et al. Proposed diagnostic criteria for the Brugada syndrome: Consensus report. Circulation 2002; 106: 2514-2519.

3. Mivelaz Y, Di Bernardo S, Pruvot E, Meijboom EJ, Sekarski N. Brugada syndrome in childhood: A potential fatal arrhythmia not always recognised by paediatricians. A case report and review of the literature. Eur J Pediatr 2006; 165: 507-511.

4. Keller DI, Rougier JS, Kucera JP, et al. Brugada syndrome and fever: Genetic and molecular characterization of patients carrying SCN5A mutations. Cardiovasc Res 2005; 67: 510-519.

5. Antzelevitch C, Brugada P, Borggrefe M, et al. Brugada syndrome: Report of the second consensus conference: endorsed by the Heart Rhythm Society and the European Heart Rhythm Association. Circulation 2005; 111: 659-670.

6. Probst V, Denjoy I, Meregalli PG, et al. Clinical aspects and prognosis of Brugada syndrome in children. Circulation 2007; 115: 2042-2048.

7. Vohra J. Diagnosis and management of Brugada Syndrome. Heart Lung Circ 2011; 20: 751-756.

8. De Marco S, Giannini C, Chiavaroli V, De Leonibus C, Chiarelli F, Mohn A. Brugada syndrome unmasked by febrile illness in an asymptomatic child. J Pediatr 2012; 16: 769.

9. Skinner JR, Chung SK, Nel CA, et al. Brugada syndrome masquerading as febrile seizures. Pediatrics 2007; 119: 1206-1211.

10. Chen Q, Kirsch GE, Zhang D, et al. Genetic basis and molecular mechanism for idiopathic ventricular fibrillation. Nature 1998; 392: 293-296.

11. Adler A, Topaz G, Heller K, et al. Fever-induced Brugada pattern: How common is it and what does it mean? Heart Rhythm 2013; 10:1375-1382.

12. Viskin S, Wilde AAM, Tan HL, Antzelevitch C, Shimizu W, Belhassen B. Empiric quinidine therapy for asymptomatic Brugada syndrome: Time for a prospective registry. Heart Rhythm 2009; 6: 401-404.

13. Nerbonne JM, Kass RS. Molecular physiology of cardiac repolarization. Physiol Rev 2005; 85: 1205-1213.

14. Wang Q, Shen J, Splawski I, et al. SCN5A mutations associated with an inherited cardiac arrhythmia, long QT syndrome. Cell 1995; 80: 805-811.

15. McNair WP, Ku L, Taylor MR, et al. SCN5A mutation associated with dilated cardiomyopathy, conduction disorder, and arrhythmia. Circulation 2004; 110: 2163- 2167.

16. Ge J, Sun A, Paajanen V, et al. Molecular and clinical characterization of a novel SCN5A mutation associated with atrioventricular block and dilated cardiomyopathy. Circ Arrhythm Electrophysiol 2008; 1: 83-92.

17. Keller DI, Huang H, Zhao J, et al. A novel SCN5A mutation, F1344S, identified in a patient with Brugada syndrome and fever-induced ventricular fibrillation. Cardiovascular Research 2006; 70: 521-529.

18. Dumaine R, Towbin JA, Brugada P, et al. Ionic mechanisms responsible for the electrocardiographic phenotype of the Brugada syndrome are temperature dependent. Circ Res 1999; 85: 803-809.

19. Makielski JC, Ye B, Valdivia CR, et al. A ubiquitous splice variant and a common polymorphism affect heterologous expression of recombinant human SCN5A heart sodium channels. Circ Res 2003; 93: 821-828.

20. Cheng J, Morales A, Siegfried JD, et al. SCN5A rare variants in familial dilated cardiomyopathy decrease peak sodium current depending on the common polymorphism H558R and common splice variant Q1077del. Clin Transl Sci 2010; 3: 287-294.

21. Viswanathan PC, Benson DW, Balser JR. A common SCN5A polymorphism modulates the biophysical effects of an SCN5A mutation. J Clin Invest 2003; 111: 341-346.